QRVO
54
-9
OXY
50
-2
TXT
60
-5
BXP
38
4
MAT
58
2
DG
32
2
DNB
20
2
JCI
46
2
THC
65
-3
AES
35
2
PCAR
56
-5
ACN
36
5
FSLR
47
-5
XEL
55
5
CMCSA
57
4
WAT
44
-4
AMZN
58
-2
HCA
35
-5
PEP
66
3
DHI
45
-9
QRVO
54
-9
OXY
50
-2
TXT
60
-5
BXP
38
4
MAT
58
2
DG
32
2
DNB
20
2
JCI
46
2
THC
65
-3
AES
35
2
PCAR
56
-5
ACN
36
5
FSLR
47
-5
XEL
55
5
CMCSA
57
4
WAT
44
-4
AMZN
58
-2
HCA
35
-5
PEP
66
3
DHI
45
-9
Financhill
Back

Intelligent Bio Solutions 10K Form

Sell
18

INBS
Intelligent Bio Solutions

Last Price:
2.74
Seasonality Move:
-17.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBS News And Ratings

See the #1 stock for the next 7 days that we like better than INBS

INBS Financial Statistics

Sales & Book Value

Annual Sales: $1.26M
Cash Flow: $-2.93M
Price / Cash Flow: 0
Annual Sales: $2.22
Price / Book: 1.83

Profitability

EPS (TTM): -128.88000
Net Income (TTM): $-13.4M
Gross Margin: $326.67K
Return on Equity: -276.04%
Return on Assets: -118.36%

Intelligent Bio Solutions Earnings Forecast

Key Intelligent Bio Solutions Financial Ratios

  • The Gross Profit Margin over the past 2 years for INBS is 25.99%.
  • The Selling, General & Administrative Expenses for INBS have been equal to 638.63% of Gross Profit Margin.
  • The Research & Development expenses have been 40.37% of Revenue.
  • The Interest Expense is -2.10% of Operating Income.
  • The Net Earning history of INBS is -845.89% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Intelligent Bio Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: INBS
Website: gbs.inc

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 0.57
Quick Ratio: 0.32

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBS Technical Analysis vs Fundamental Analysis

Sell
18
Intelligent Bio Solutions (INBS) is a Sell

Is Intelligent Bio Solutions a Buy or a Sell?